Regeneron Pharmaceuticals
The Associate Director leads model-informed drug development strategies within the Quantitative Pharmacology group, supporting therapeutic areas across various modalities. This role combines scientific expertise with cross-functional leadership to inform dose selection, trial design, and regulatory strategy from early development through submission. The position involves providing significant pharmacometrics contributions and overseeing quantitative analyses to address strategic program needs and regulatory hurdles.
Headquarters
Tarrytown, New York, United States
Company Size
10001+ employees
Founded
1988
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Quadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN
4 hours ago
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
6 hours ago
Will Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative?
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
Regeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)
1 day ago
Sr. Director, Clinical Pharmacology & Pharmacometrics
GondolaBio Service Co, Inc.
Postdoctoral Research Associate
Northeastern University
Senior Director, Clinical Pharmacology
Beeline Medicines
Director of Quantitative & Clinical Pharmacology
Sarepta Therapeutics
Postdoctoral Research Fellow, Moderna - Clinical & Quantitative Pharmacology
Northeastern University
Senior Dir, Clinical Pharmacology & Pharmacometrics
Bristol Myers Squibb